Article
Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy.
Kidney international - 1 May 2013
Kanigicherla Durga, Gummadova Jennet, McKenzie Edward A, Roberts Stephen A, Harris Shelley, Nikam Milind, Poulton Kay, McWilliam Lorna, Short Colin D, Venning Michael, Brenchley Paul E
Abstract excerpt
Antibodies to the phospholipase A2 receptor 1 (PLA2R1) have been reported in 70% of cases of idiopathic membranous nephropathy (IMN). The genetic susceptibility of IMN has been accounted for by HLA DQA1 and PLA2R1 genes. Here we retrospectively quantified PLA2R antibodies by ELISA, and genotyped...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
